Virax Biolabs Group Limited (VRAX)Healthcare | Biotechnology | Lanarkshire, United Kingdom | NasdaqCM
0.15 USD
0.00
(-1.056%) ⇩
(April 17, 2026, 4 p.m.
EDT)
After hours: 0.14 -0.01 (-0.006%) ⇩ (April 17, 2026, 7:58 p.m. EDT) Short-term: ★☆☆☆☆ | Long-term: ★☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 11, 2026, 3:30 p.m. EDT
VRAX (Virax Biolabs Group Limited) presents a highly volatile and uncertain investment profile. The stock has experienced significant price swings, with a recent close of $0.1041, which is near its 52-week low of $0.10. The negative forward PE, trailing EPS, and operating margins suggest poor financial performance and lack of profitability. The stock's low market cap and high debt-to-equity ratio indicate substantial financial risk. While recent news highlights clinical progress and private placements, these are not enough to offset the overall negative fundamentals. The short-term price forecasting model predicts a significant decline, further indicating a bearish outlook. Given the lack of dividends and the overall negative financial indicators, this stock is not suitable for short-term or long-term investment. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.078814 |
| AutoARIMA | 0.316366 |
| AutoETS | 0.316375 |
| MSTL | 0.345159 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 62% |
| H-stat | 1.93 |
| Ljung-Box p | 0.006 |
| Jarque-Bera p | 0.545 |
| Excess Kurtosis | 0.69 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 10.604 |
| Revenue per Share | 0.001 |
| Market Cap | 1,112,772 |
| Forward P/E | -0.62 |
| Beta | 1.60 |
| Website | https://viraxbiolabs.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.8335159 |
| Address1 | BioCity Glasgow |
| Address2 | Bo’Ness Road Newhouse |
| All Time High | 290.0 |
| All Time Low | 0.1 |
| Ask | 0.1685 |
| Ask Size | 1 |
| Average Daily Volume10 Day | 51,719,820 |
| Average Daily Volume3 Month | 12,700,285 |
| Average Volume | 12,700,285 |
| Average Volume10Days | 51,719,820 |
| Beta | 1.598 |
| Bid | 0.1229 |
| Bid Size | 1 |
| Book Value | 0.812 |
| City | Lanarkshire |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United Kingdom |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.1499 |
| Current Ratio | 11.354 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 0.1499 |
| Day Low | 0.135 |
| Debt To Equity | 10.604 |
| Display Name | Virax Biolabs |
| Ebitda | -5,556,497 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | 0.388 |
| Enterprise To Revenue | -722.526 |
| Enterprise Value | -2,157,463 |
| Eps Current Year | -0.4 |
| Eps Forward | -0.24 |
| Eps Trailing Twelve Months | -1.22 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 0.19338 |
| Fifty Day Average Change | -0.043479994 |
| Fifty Day Average Change Percent | -0.22484225 |
| Fifty Two Week Change Percent | -83.351585 |
| Fifty Two Week High | 1.2 |
| Fifty Two Week High Change | -1.0501001 |
| Fifty Two Week High Change Percent | -0.8750834 |
| Fifty Two Week Low | 0.1 |
| Fifty Two Week Low Change | 0.049900003 |
| Fifty Two Week Low Change Percent | 0.499 |
| Fifty Two Week Range | 0.1 - 1.2 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,658,410,200,000 |
| Float Shares | 5,502,241 |
| Forward Eps | -0.24 |
| Forward P E | -0.62458336 |
| Free Cashflow | -3,539,977 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 19 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Gross Profits | -45,306 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.01793 |
| Held Percent Institutions | 0.043109998 |
| Implied Shares Outstanding | 7,423,432 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Ipo Expected Date | 2,022-07-21 |
| Language | en-US |
| Last Fiscal Year End | 1,743,379,200 |
| Last Split Date | 1,702,857,600 |
| Last Split Factor | 1:10 |
| Long Business Summary | Virax Biolabs Group Limited, a biotechnology company, distributes diagnostics test kits for the prevention, detection, diagnosis, and risk management of viral diseases in the field of T cell in Vitro Diagnostics. The company offers various in-vitro diagnostics test kits comprising respiratory, pregnancy and fertility, infectious diseases, sti, drugs of abuse, oncology, cardiac, women's health, other test kits under the ViraxClear brands; and rapid and molecular tests for small animal veterinary diagnostics under the ViraxVet brand. It also provides ViraxImmune, a T cell In vitro diagnostic device and wellness mobile application; and service, such as antibody engineering, custom peptides, protein sequencing, vaccine efficacy testing, immunology lab services, kits and reagents. In addition, the company is involved in research and development activities; and provision of procurement, warehousing, product development, and staffing management services. It serves research organizations, corporations, independent laboratories, large hospital systems and public and private institutions, as well as distributor customers. The company operates in the United Kingdom, the United States, and China. The company was formerly known as Virax Biolabs (Cayman) Limited and changed its name to Virax Biolabs Group Limited in September 2021. Virax Biolabs Group Limited was founded in 2013 and is headquartered in Lanarkshire, the United Kingdom. |
| Long Name | Virax Biolabs Group Limited |
| Market | us_market |
| Market Cap | 1,112,772 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_1685878340 |
| Most Recent Quarter | 1,759,190,400 |
| Net Income To Common | -5,643,591 |
| Next Fiscal Year End | 1,774,915,200 |
| Non Diluted Market Cap | 1,097,183 |
| Number Of Analyst Opinions | 1 |
| Open | 0.1476 |
| Operating Cashflow | -5,405,240 |
| Operating Margins | -1,607.8832 |
| Payout Ratio | 0.0 |
| Phone | 44 20 7788 7414 |
| Post Market Change | -0.0059999973 |
| Post Market Change Percent | -4.0026665 |
| Post Market Price | 0.1439 |
| Post Market Time | 1,776,470,288 |
| Previous Close | 0.1515 |
| Price Eps Current Year | -0.37475002 |
| Price Hint | 4 |
| Price To Book | 0.18460593 |
| Price To Sales Trailing12 Months | 372.6631 |
| Profit Margins | 0.0 |
| Quick Ratio | 9.887 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.0016 |
| Regular Market Change Percent | -1.0561 |
| Regular Market Day High | 0.1499 |
| Regular Market Day Low | 0.135 |
| Regular Market Day Range | 0.135 - 0.1499 |
| Regular Market Open | 0.1476 |
| Regular Market Previous Close | 0.1515 |
| Regular Market Price | 0.1499 |
| Regular Market Time | 1,776,456,000 |
| Regular Market Volume | 3,166,809 |
| Return On Assets | -0.48403 |
| Return On Equity | -0.83822 |
| Revenue Growth | -0.675 |
| Revenue Per Share | 0.001 |
| Sand P52 Week Change | 0.36506534 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 7,423,432 |
| Shares Percent Shares Out | 0.0 |
| Shares Short | 211 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 55,704 |
| Short Name | Virax Biolabs Group Limited |
| Short Percent Of Float | 0.0 |
| Short Ratio | 0.0 |
| Source Interval | 15 |
| Symbol | VRAX |
| Target High Price | 1.0 |
| Target Low Price | 1.0 |
| Target Mean Price | 1.0 |
| Target Median Price | 1.0 |
| Total Cash | 3,437,848 |
| Total Cash Per Share | 0.525 |
| Total Debt | 537,993 |
| Total Revenue | 2,986 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -1.22 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 0.48969 |
| Two Hundred Day Average Change | -0.33979 |
| Two Hundred Day Average Change Percent | -0.69388795 |
| Type Disp | Equity |
| Volume | 3,166,809 |
| Website | https://viraxbiolabs.com |
| Zip | ML1 5UH |